One patient with central nervous system leukemia who received DAP12-BB CAR-T treatment also achieved CR, suggesting that DAP12-BB CAR-T cells can migrate into the tumor site and exert an antitumor effect in bone marrow and the central nervous system. Here, TYROBP is linked to central nervous system leukemia.